Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs. It also provides outpatient community-based services, such as community-based programs that are designed to offer therapeutic treatment to children and adolescents who have a clinically-defined emotional, psychiatric, or chemical dependency disorder. In addition, the company provides mental health services; rehabilitation services comprising relapse prevention and social integration services, as well as vocational opportunities; acute services for patients at risk to themselves or others, as well as crisis intervention and treatment of behavioral emergencies; and long-term and non-acute care services for adults suffering from mental illness, addiction, learning disability, or brain injury. Further, it provides education and children's services for children and young people with special educational needs; adult and elderly care services; and care first services for employees. As of December 31, 2017, the company operated a network of 582 behavioral healthcare facilities with approximately 17,800 beds in the United States, the United Kingdom, and Puerto Rico. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Specialty outpatient clinics, not elsewhere classified
Sub-IndustryHealth Care Facilities
SectorMedical
SymbolNASDAQ:ACHC
CUSIP00404A10
Phone615-861-6000
Debt
Debt-to-Equity Ratio1.20
Current Ratio1.24
Quick Ratio1.24
Price-To-Earnings
Trailing P/E Ratio14.48
Forward P/E Ratio13.21
P/E Growth1.26
Sales & Book Value
Annual Sales$2.84 billion
Price / Sales1.04
Cash Flow$3.8014 per share
Price / Cash8.76
Book Value$29.29 per share
Price / Book1.14
Profitability
EPS (Most Recent Fiscal Year)$2.30
Net Income$199.83 million
Net Margins7.52%
Return on Equity7.93%
Return on Assets3.19%
Miscellaneous
Employees27,500
Outstanding Shares88,270,000
Market Cap$3.11 billion
Acadia Healthcare (NASDAQ:ACHC) Frequently Asked Questions
What is Acadia Healthcare's stock symbol?
Acadia Healthcare trades on the NASDAQ under the ticker symbol "ACHC."
How were Acadia Healthcare's earnings last quarter?
Acadia Healthcare Company Inc (NASDAQ:ACHC) released its quarterly earnings results on Monday, July, 30th. The company reported $0.70 EPS for the quarter, hitting the Thomson Reuters' consensus estimate of $0.70. The business earned $765.70 million during the quarter, compared to analysts' expectations of $767.93 million. Acadia Healthcare had a return on equity of 7.93% and a net margin of 7.52%. The company's quarterly revenue was up 5.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.66 earnings per share. View Acadia Healthcare's Earnings History.
When is Acadia Healthcare's next earnings date?
What guidance has Acadia Healthcare issued on next quarter's earnings?
Acadia Healthcare issued an update on its FY18 earnings guidance on Monday, July, 30th. The company provided earnings per share guidance of $2.52-2.56 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.59. The company issued revenue guidance of $3.02-3.06 billion, compared to the consensus revenue estimate of $3.06 billion.
What price target have analysts set for ACHC?
13 equities research analysts have issued twelve-month target prices for Acadia Healthcare's stock. Their predictions range from $37.00 to $59.00. On average, they anticipate Acadia Healthcare's share price to reach $44.0769 in the next twelve months. This suggests a possible upside of 32.4% from the stock's current price. View Analyst Price Targets for Acadia Healthcare.
What is the consensus analysts' recommendation for Acadia Healthcare?
13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Acadia Healthcare in the last year. There are currently 5 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Acadia Healthcare.
What are Wall Street analysts saying about Acadia Healthcare stock?
Here are some recent quotes from research analysts about Acadia Healthcare stock:
- 1. According to Zacks Investment Research, "Acadia Healthcare’s shares have outperformed its industry’s growth year to date. In the past 60 days, the company has witnessed its 2018 and 2019 earnings estimates rise upward, which reflects investors' optimism on the stock. Better-than-expected earnings were driven by revenue growth led by the addition of beds. The company is well positioned for long-term growth on the back of its inorganic strategies. Its latest Priory acquisition has substantially enhanced its asset base, making it the largest independent provider of mental health services in the U.K. However, the company suffers from high debt, escalating interest expenses and foreign exchange fluctuations. Substantial integration risks associated with its frequent acquisitions are the major headwinds." (7/24/2018)
- 2. Mizuho analysts commented, "fix the U.K. issues away from public scrutiny." The problem is the balance sheet's debt to EBITDA leverage of roughly 5.4x, which serves as a notable obstacle towards a go-private deal.But Acadia's woes are also domestic-based as the Centers for Medicare & Medicaid Services (CMS) proposed on Friday a change to a rule that gives states more flexibility to interpret the ACA's 10 essential benefit requirements — one of which includes mental health."Given the national focus on mental health and addiction, we would be surprised if these benefits are at risk," Hynes also said. "However, it could provide an overhang on an already fragile stock." (10/29/2017)
- 3. Cantor Fitzgerald analysts commented, "3Q17 falls short. ACHC reported 3Q17 adjusted EPS of $0.58 (including $0.02 of costs due to last month’s hurricanes), vs. our $0.64 estimate and the $0.65 FactSet consensus. Adjusted EBITDA was $152.3 million, vs. our $160.8 million estimate and the $163 million consensus." (10/24/2017)
Who are some of Acadia Healthcare's key competitors?
Some companies that are related to Acadia Healthcare include MERCK KGAA/S (MKKGY), H. Lundbeck A/S- (HLUYY), Seattle Genetics (SGEN), Teleflex (TFX), Straumann (SAUHF), Davita (DVA), Universal Health Services, Inc. Class B (UHS), Sino Biopharmaceutical (SBMFF), AEGON N.V. (EPA) (AGN), Smith & Nephew (SN), Canopy Growth (CGC), Hologic (HOLX), Neurocrine Biosciences (NBIX), Cochlear (COH) and Sarepta Therapeutics (SRPT).
Who are Acadia Healthcare's key executives?
Acadia Healthcare's management team includes the folowing people:
- Mr. Joey A. Jacobs, Chairman & CEO (Age 65)
- Mr. William Brent Turner, Pres (Age 52)
- Mr. David M. Duckworth, CFO, Chief Accounting Officer & Controller (Age 38)
- Mr. Ronald Morgon Fincher, Chief Operating Officer (Age 65)
- Mr. Christopher L. Howard, Exec. VP, Gen. Counsel & Sec. (Age 51)
Who are Acadia Healthcare's major shareholders?
Acadia Healthcare's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Copper Rock Capital Partners LLC (0.42%) and Corrado Advisors LLC (0.08%). Company insiders that own Acadia Healthcare stock include Brent Turner, Christopher L Howard, Joey A Jacobs, Randall P Goldberg, Reeve B Waud, Ronald Morgan Fincher, Scott Schwieger and William Grieco. View Institutional Ownership Trends for Acadia Healthcare.
Which major investors are selling Acadia Healthcare stock?
ACHC stock was sold by a variety of institutional investors in the last quarter, including Copper Rock Capital Partners LLC and Corrado Advisors LLC. Company insiders that have sold Acadia Healthcare company stock in the last year include Randall P Goldberg and Reeve B Waud. View Insider Buying and Selling for Acadia Healthcare.
How do I buy shares of Acadia Healthcare?
Shares of ACHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Acadia Healthcare's stock price today?
One share of ACHC stock can currently be purchased for approximately $33.30.
How big of a company is Acadia Healthcare?
Acadia Healthcare has a market capitalization of $3.11 billion and generates $2.84 billion in revenue each year. The company earns $199.83 million in net income (profit) each year or $2.30 on an earnings per share basis. Acadia Healthcare employs 27,500 workers across the globe.
What is Acadia Healthcare's official website?
How can I contact Acadia Healthcare?
Acadia Healthcare's mailing address is 6100 TOWER CIRCLE SUITE 1000, FRANKLIN TN, 37067. The company can be reached via phone at 615-861-6000.
MarketBeat Community Rating for Acadia Healthcare (NASDAQ ACHC)
MarketBeat's community ratings are surveys of what our community members think about Acadia Healthcare and other stocks. Vote "Outperform" if you believe ACHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ACHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
